(Q36194084)

12 August 2017

1 reference

title

The role of adjuvants in the development of mucosal vaccines (English)

1 reference

12 August 2017

Michael Vajdy

1

1 reference

PubMed ID

16018740

12 August 2017

Manmohan Singh

series ordinal

2

1 reference

PubMed ID

16018740

12 August 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

Expert Opinion on Biological Therapy

12 August 2017

1 reference

12 August 2017

5

1 reference

12 August 2017

7

1 reference

12 August 2017

953-965

1 reference

Regional specialization in the mucosal immune system: what happens in the microcompartments?

12 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Human nasopharyngeal-associated lymphoreticular tissues. Functional analysis of subepithelial and intraepithelial B and T cells from adenoids and tonsils

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Intranasal immunization of mice with herpes simplex virus type 2 recombinant gD2: the effect of adjuvants on mucosal and serum antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Epithelial M cells: gateways for mucosal infection and immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Rectal immunization for induction of specific antibody in the genital tract of women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Differential effects of simian immunodeficiency virus infection on immune inductive and effector sites in the rectal mucosa of rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Exploiting dendritic cells to improve vaccine efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3alpha, MIP-3beta, and secondary lymphoid organ chemokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Modulating vaccine responses with dendritic cells and Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

LT(R192G), a non-toxic mutant of the heat-labile enterotoxin of Escherichia coli, elicits enhanced humoral and cellular immune responses associated with protection against lethal oral challenge with Salmonella spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

The adjuvant effect of a non-toxic mutant of heat-labile enterotoxin of Escherichia coli for the induction of measles virus-specific CTL responses after intranasal co-immunization with a synthetic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Potency of a genetically detoxified mucosal adjuvant derived from the heat-labile enterotoxin of Escherichia coli (LTK63) is not adversely affected by the presence of preexisting immunity to the adjuvant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

From toxin to adjuvant: the rational design of a vaccine adjuvant vector, CTA1-DD/ISCOM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Bacterial cell wall products as adjuvants: early interferon gamma as a marker for adjuvants that enhance protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

A Th1-inducing adjuvant, MPL, enhances antibody profiles in experimental animals suggesting it has the potential to improve the efficacy of allergy vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Intranasal immunization with multivalent group A streptococcal vaccines protects mice against intranasal challenge infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Use of cellular and cytokine adjuvants in the immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Systemic immunological effects of cytokine genes injected into skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

CpG motifs in bacterial DNA trigger direct B-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Toll-like receptor 9, CpG DNA and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Plasmacytoid dendritic cells: the key to CpG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

A Toll-like receptor recognizes bacterial DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

CpG motifs in bacterial DNA and their immune effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Lectin-mediated mucosal delivery of drugs and microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Glycoconjugate expression defines the origin and differentiation pathway of intestinal M-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Immunological implications of the use of plant lectins for drug and vaccine targeting to the gastrointestinal tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Mistletoe lectins enhance immune responses to intranasally co-administered herpes simplex virus glycoprotein D2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Biodegradable microspheres in drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Macrophage phagocytosis of biodegradable microspheres composed of L-lactic acid/glycolic acid homo- and copolymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Analysis of poly(D,L-lactic-co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Intranasal immunization with polymer-grafted microparticles activates the nasal-associated lymphoid tissue and draining lymph nodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Polymer-grafted starch microparticles for oral and nasal immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Mucosal immune responses following oral immunization with rotavirus antigens encapsulated in alginate microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Immunologic aspects of liposomes: presentation and processing of liposomal protein and phospholipid antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Immunological adjuvants: a role for liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Immunogenicity and protectivity of a new liposomal hepatitis A vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

ISCOMs and other saponin based adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Augmentation of human influenza A virus-specific cytotoxic T lymphocyte memory by influenza vaccine and adjuvanted carriers (ISCOMS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Transmucosal macromolecular drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Advances in vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Maintenance of long-term immunological memory by low avidity IgM-secreting cells in bone marrow after mucosal immunizations with cholera toxin adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Germinal centers and antibody production in bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

Action of Saponin on Biological Cell Membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.7.953

21 January 2018

Identifiers

DOI

10.1517/14712598.5.7.953

1 reference

12 August 2017

1 reference

PubMed ID

16018740